Reporte zur Charge 043120A/043L20A

Symptomtext

It has been more than 36 days and the patient did not get the second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It has been more than 36 days and the patient did not get the second dose yet) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043120A/043L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no reported medical history). On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It has been more than 36 days and the patient did not get the second dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It has been more than 36 days and the patient did not get the second dose yet) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment information provided. This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot #unknown, with no associated AEs.; Sender's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot #unknown, with no associated AEs.